Fatal Case of Metformin-Associated Lactic Acidosis Associated With Temporary Ileostomy: A Case Report : Journal of Wound Ostomy & Continence Nursing

Secondary Logo

Journal Logo

Challenges in Practice

Fatal Case of Metformin-Associated Lactic Acidosis Associated With Temporary Ileostomy

A Case Report

Tirelli, Flavio; Biondi, Alberto; Persiani, Roberto

Author Information
Journal of Wound, Ostomy and Continence Nursing 45(4):p 364-365, July/August 2018. | DOI: 10.1097/WON.0000000000000447



Metformin is considered a first choice for oral treatment of patients with type 2 diabetes in the absence of contraindications. Colorectal cancer is the second most frequent cancer among the general population; low anterior resections and temporary diverting ileostomies are commonly performed in this population. As the incidence of type 2 diabetes increases, the use of metformin in patients with both type 2 diabetes and an ileostomy will most likely increase as well.


We present the case of a patient affected by colorectal cancer who developed a severe metformin-associated lactic acidosis (MALA) after creation of a temporary ileostomy to protect a low colorectal anastomosis. High-volume output from his ileostomy led to significant fluid loss and electrolyte imbalance, his condition was complicated by MALA, resulting in death.


The population of ileostomy patients who also have type 2 diabetic and taking metformin is at risk for MALA. High stomal output can lead to dehydration, with a loss of fluids and electrolytes and metformin could aggravate this condition, potentiating the risk of MALA.

© 2018 by the Wound, Ostomy and Continence Nurses Society

You can read the full text of this article if you:

Access through Ovid